-
EP2860195
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2860195
| EP2860195 - Treatment of IgE-mediated disease [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 11.03.2016 Database last updated on 22.05.2024 | Most recent event Tooltip | 11.03.2016 | Application deemed to be withdrawn | published on 13.04.2016 [2016/15] | Applicant(s) | For all designated states Boston Medical Center Corporation One Boston Medical Center Place Boston, MA 02118 / US | For all designated states Trustees of Boston University One Silber Way Boston, MA 02215 / US | [2015/16] | Inventor(s) | 01 /
Ganley-Leal, Lisa 63 Bowen Street Newton, Massachusetts 02459 / US | 02 /
Connor, John H. 135 Cornell Street Newton, Massachusetts 02462 / US | [2015/16] | Representative(s) | Brown, David Leslie Haseltine Lake Kempner LLP Redcliff Quay 120 Redcliff Street Bristol BS1 6HU / GB | [N/P] |
| Former [2015/16] | Brown, David Leslie Haseltine Lake LLP Redcliff Quay 120 Redcliff Street Bristol BS1 6HU / GB | Application number, filing date | 14194611.1 | 01.12.2010 | [2015/16] | Priority number, date | US20090265439P | 01.12.2009 Original published format: US 265439 P | [2015/16] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2860195 | Date: | 15.04.2015 | Language: | EN | [2015/16] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 16.03.2015 | Classification | IPC: | C07K19/00, C07K14/705, A61K38/17, A61P37/08 | [2015/16] | CPC: |
A61K31/56 (EP,US);
A61K38/17 (EP,US);
A61K39/0005 (US);
A61K45/06 (EP,US);
A61P11/02 (EP);
A61P11/06 (EP);
A61P17/00 (EP);
A61P17/04 (EP);
A61P37/06 (EP);
A61P37/08 (EP);
A61P43/00 (EP);
C07K14/195 (EP,US);
| C-Set: |
A61K31/56, A61K2300/00 (EP,US);
A61K38/17, A61K2300/00 (US,EP) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/48] |
| Former [2015/16] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | Behandlung von IgE-vermittelten Erkrankungen | [2015/16] | English: | Treatment of IgE-mediated disease | [2015/16] | French: | Traitement de maladies à médiation par IgE | [2015/16] | Examination procedure | 14.10.2015 | Examination requested [2015/48] | 16.10.2015 | Application deemed to be withdrawn, date of legal effect [2016/15] | 25.11.2015 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time [2016/15] | Parent application(s) Tooltip | EP10835042.2 / EP2507266 | Fees paid | Renewal fee | 24.11.2014 | Renewal fee patent year 03 | 24.11.2014 | Renewal fee patent year 04 | 24.11.2014 | Renewal fee patent year 05 | 28.12.2015 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]WO2009103067 (PHILADELPHIA CHILDREN HOSPITAL [US], et al) [X] 1,7-11 * sequence 2 * [I] 2; | [XI]EP1642974 (MAX PLANCK GESELLSCHAFT [DE]) [X] 1 * figure 11; sequence 6 * [I] 2; | [XI]WO2006067406 (ISIS INNOVATION [GB], et al) [X] 1,7-11 * sequence 3 * [I] 2; | [A]WO9965524 (UNIV VIRGINIA COMMONWEALTH [US]) [A] 1 * page 2, line 25 - line 27 *; | [IL] - SCHULZ O ET AL, "CLEAVAGE OF THE LOW-AFFINITY RECEPTOR FOR HUMAN IGE (CD23) BY A MITE CYSTEINE PROTEASE: NATURE OF THE CLEAVED FRAGMENT IN RELATION TO THE STRUCTURE AND FUNCTION OF CD23", EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY - V C H VERLAG GMBH & CO. KGAA, DE, (19970101), vol. 27, no. 3, doi:10.1002/EJI.1830270303, ISSN 0014-2980, pages 583 - 588, XP009063071 [I] 1,2,8-11 * the whole document * [L] 3,6 DOI: http://dx.doi.org/10.1002/eji.1830270303 | [XI] - GRIFFITH QYANA ET AL, "SCHISTOSOMES TARGET HUMAN CD23-MEDIATED IMMUNITY IN IMMUNO-EVASIVE TACTICS", AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, & 58TH ANNUAL MEETING OF THE AMERICAN-SOCIETY-OF-TROPICAL-MEDICINE-AND-HYGIENE; WASHINGTON, DC, USA; NOVEMBER 18 -22, 2009, (20091118), vol. 81, no. 5, Suppl. S, ISSN 0002-9637, page 99, XP002695459 [X] 1 * the whole document * [I] 2 | [L] - HIBBERT R G ET AL, "The structure of human CD23 and its interactions with IgE and CD21", THE JOURNAL OF EXPERIMENTAL MEDICINE, ROCKEFELLER UNIVERSITY PRESS, US, (20050919), vol. 202, no. 6, doi:10.1084/JEM.20050811, ISSN 0022-1007, pages 751 - 760, XP002371177 [L] 3,4 * abstract * * page 755, column l, paragraph 2 - column r, paragraph 2 * DOI: http://dx.doi.org/10.1084/jem.20050811 | by applicant | US6673965 | US6235753 | US5206347 | US4968317 | US5618563 | - CHEN ET AL., J IMMUNOLOGICAL METHODS, (1983), vol. 58, no. 1-2, pages 59 - 7L | - MATSUO, J IMMUNOLOGY, (2005), vol. 175, pages 8116 - 8122 | - DANIELS, B. ET AL., CELLULAR IMMUNITY, (2005), vol. 234, no. 2, pages 146 - 153 | - ADVANCED DRUG REVIEWS, (1995), vol. 6, pages 157 - 182 |